News + Filings Holdings
All
13F
13D/G
Other
|
|
Broadfin Capital, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/22/2022 |
4
| KOTLER KEVIN (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Disposed of 7,588,395 shares
@ $0
Disposed/sold 22,685 restricted stock units
@ $0
Disposed/sold 7,500 options to buy
@ $2.93, valued at
$22k
Disposed/sold 85,760 options to buy
@ $3.66, valued at
$313.9k
|
|
| 02/15/2022 |
4
| KOTLER KEVIN (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Converted 2,422,222 shares
@ $1.8, valued at
$4.4M
Converted 436 convertible preferred
@ $1.8, valued at
$784.8 |
|
| 01/31/2022 |
4
| KOTLER KEVIN (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Granted 85,760 options to buy
@ $0
Granted 15,369 restricted stock units
@ $0
Exercised 7,684 restricted stock units
@ $0 |
|
| 11/22/2021 |
4
| KOTLER KEVIN (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Bought 100,000 shares
@ $3.06, valued at
$306k
|
|
| 11/15/2021 |
4
| KOTLER KEVIN (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Bought 100,000 shares
@ $3.2, valued at
$320k
|
|
| 11/09/2021 |
4
| KOTLER KEVIN (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Bought 257,800 shares
@ $3.47, valued at
$894.6k
|
|
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/19/2020 |
4
| Broadfin Healthcare Master Fund Ltd (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Exercised 10,623 shares
@ $2.93, valued at
$31.1k
Converted 10,623 options
@ $2.93, valued at
$31.1k
|
|
| 12/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2019 |
4
| KOTLER KEVIN (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Exercised 18,123 shares
@ $0
Exercised 18,123 restricted stock units
@ $0 |
|
| 08/09/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/22/2019 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on ARATANA THERAPEUTICS, INC.|
Txns:
| Disposed/sold 7,258,135 shares
@ $0 |
|
| 05/14/2019 |
4
| Broadfin Healthcare Master Fund Ltd (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Sold 1,800,000 shares
@ $5, valued at
$9M
Converted 324 convertible preferred
@ $1.8, valued at
$583.2 |
|
| 04/15/2019 |
4
| Broadfin Healthcare Master Fund Ltd (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Sold 2,000,000 shares
@ $5, valued at
$10M
Converted 360 convertible preferred
@ $1.8, valued at
$648 |
|
| 02/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/27/2018 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on NOVELION THERAPEUTICS INC.|
Txns:
| Sold 400 shares
@ $0.98, valued at
$392
Sold 1,200 shares
@ $0.9325, valued at
$1.1k
Sold 83,245 shares
@ $0.9784, valued at
$81.4k
Sold 12,450 shares
@ $0.9078, valued at
$11.3k
Sold 109,900 shares
@ $0.872, valued at
$95.8k
Sold 12,219 shares
@ $0.9091, valued at
$11.1k
Sold 28,745 shares
@ $0.9058, valued at
$26k
Sold 30,726 shares
@ $0.907, valued at
$27.9k
Sold 14,800 shares
@ $0.8803, valued at
$13k
Sold 56,316 shares
@ $0.8548, valued at
$48.1k
Sold 100,000 shares
@ $0.8514, valued at
$85.1k
|
|
| 11/28/2018 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on Corium International, Inc.|
Txns:
| Unknown transaction of 4,474,995 shares
@ $0 |
|
| 08/16/2018 |
4
| KOTLER KEVIN (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Exercised 3,124 restricted stock units
@ $0 |
|
| 08/13/2018 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on NOVELION THERAPEUTICS INC.|
Txns:
| Gifted 10,000 options to buy
@ $0 |
|
| 08/03/2018 |
4
| KOTLER KEVIN (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Granted 96,247 restricted stock units
@ $0
Granted 48,123 options to buy
@ $2.93, valued at
$141k
|
|
| 05/24/2018 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on Recro Pharma, Inc.|
Txns:
| Sold 29,300 shares
@ $5.84, valued at
$171.1k
Sold 38,000 shares
@ $5.99, valued at
$227.6k
Sold 45,700 shares
@ $6, valued at
$274.2k
Sold 50,000 shares
@ $5.65, valued at
$282.5k
Sold 25,000 shares
@ $5.51, valued at
$137.8k
|
|
| 03/19/2018 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on NOVELION THERAPEUTICS INC.|
Txns:
| Granted 909,296 warrants
@ $4.4, valued at
$4M
|
|
| 03/15/2018 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on Recro Pharma, Inc.|
Txns:
| Sold 200,000 shares
@ $10.07, valued at
$2M
|
|
| 12/22/2017 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on Recro Pharma, Inc.|
Txns:
| Sold 25,000 shares
@ $10, valued at
$250k
Sold 11,000 shares
@ $9.84, valued at
$108.2k
Sold 40,000 shares
@ $9.8, valued at
$392k
|
|
| 12/14/2017 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on Recro Pharma, Inc.|
Txns:
| Sold 25,000 shares
@ $10, valued at
$250k
Sold 100 shares
@ $9.89, valued at
$989
Sold 50,000 shares
@ $9.8, valued at
$490k
Sold 9,900 shares
@ $9.84, valued at
$97.4k
Sold 8,237 shares
@ $9.8, valued at
$80.7k
|
|
| 12/07/2017 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on Recro Pharma, Inc.|
Txns:
| Sold 100,000 shares
@ $10, valued at
$1M
|
|
| 12/01/2017 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on ARATANA THERAPEUTICS, INC.|
Txns:
| Sold 1,000 shares
@ $6.66, valued at
$6.7k
Sold 49,865 shares
@ $6.6, valued at
$329.1k
Sold 5,751 shares
@ $6.55, valued at
$37.7k
Sold 50,000 shares
@ $6.5, valued at
$325k
Sold 7,700 shares
@ $6.35, valued at
$48.9k
Sold 300 shares
@ $6.28, valued at
$1.9k
Sold 1,900 shares
@ $6.26, valued at
$11.9k
Sold 100 shares
@ $6.03, valued at
$603
Sold 11,472 shares
@ $5.97, valued at
$68.5k
Sold 100,000 shares
@ $5.95, valued at
$595k
Sold 50,000 shares
@ $5.95, valued at
$297.5k
|
|
| 11/30/2017 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on Recro Pharma, Inc.|
Txns:
| Sold 24,430 shares
@ $9.71, valued at
$237.2k
Sold 1,500 shares
@ $9.68, valued at
$14.5k
Sold 21,619 shares
@ $9.56, valued at
$206.7k
Sold 2,200 shares
@ $9.68, valued at
$21.3k
Sold 700 shares
@ $9.68, valued at
$6.8k
Sold 3,764 shares
@ $9.66, valued at
$36.4k
Sold 6,381 shares
@ $9.71, valued at
$62k
Sold 100 shares
@ $9.71, valued at
$971
Sold 6,322 shares
@ $9.63, valued at
$60.9k
Sold 500 shares
@ $9.69, valued at
$4.8k
Sold 5,000 shares
@ $9.62, valued at
$48.1k
|
|
| 11/24/2017 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on Recro Pharma, Inc.|
Txns:
| Sold 100,000 shares
@ $9.5, valued at
$950k
Sold 2,440 shares
@ $9.37, valued at
$22.9k
Sold 48,566 shares
@ $9.37, valued at
$455.1k
Sold 3,088 shares
@ $9.36, valued at
$28.9k
Sold 2,913 shares
@ $9.32, valued at
$27.1k
Sold 2,051 shares
@ $9.31, valued at
$19.1k
Sold 5,800 shares
@ $9.39, valued at
$54.5k
Sold 1,450 shares
@ $9.48, valued at
$13.7k
Sold 5,900 shares
@ $9.37, valued at
$55.3k
|
|
| 11/20/2017 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Sold 60,000 shares
@ $18.05, valued at
$1.1M
|
|
| 11/17/2017 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on Corium International, Inc.|
Txns:
| Sold 25,000 shares
@ $10.85, valued at
$271.3k
Sold 25,000 shares
@ $10.88, valued at
$272k
Sold 400 shares
@ $10.97, valued at
$4.4k
Sold 65,345 shares
@ $11.01, valued at
$719.4k
Sold 100,000 shares
@ $10.95, valued at
$1.1M
Sold 9,255 shares
@ $10.96, valued at
$101.4k
Sold 25,000 shares
@ $10.95, valued at
$273.8k
Sold 250,000 shares
@ $10.97, valued at
$2.7M
|
|
|
|
|